CenTrial Logo

Clinical Trial Evaluates Structural Valve Deterioration after Aortic Valve Replacement

by


TAVI may be better option for patients undergoing valve replacement surgery

Structural valve deterioration after aortic valve replacement is a serious issue that limits the success rates of valve replacement surgeries. A clinical trial has evaluated the incidence of structural valve deterioration (SVD) in patients undergoing self-expanding transcatheter aortic valve implantation (TAVI) and surgery.

Heart valve disease can be a serious and life-threatening condition. For patients who require aortic valve replacement, the choice between surgical or transcatheter procedures is often determined by the risk level associated with each option.

What is Structural Valve Deterioration?

Structural valve deterioration refers to the progressive damage and malfunction of a prosthetic heart valve due to structural changes in the valve material over time. SVD can lead to valve regurgitation or stenosis, which can cause symptoms such as shortness of breath, chest pain, and fatigue. If left untreated, SVD can ultimately lead to heart failure and even death. However, the frequency and clinical importance of this SVD are poorly understood.

A clinical study published in JAMA Cardiology suggests that patients who undergo self-expanding transcatheter or surgical aortic valve implantation may be at risk of developing structural valve deterioration.

The study, which was an analysis of previously conducted clinical trials, aimed to compare the rates of SVD in patients who underwent self-expanding transcatheter aortic valve replacement versus surgical aortic valve replacement (SAVR). The study included 4762 patients who were at intermediate or high risk of complications from surgical aortic valve replacement. Of these, 3791 patients underwent TAVI while 971 patients underwent SAVR.

The results of the clinical study showed that patients who underwent self-expanding transcatheter aortic valve replacement had a lower incidence of structural valve deterioration than those who underwent surgical aortic valve replacement. Specifically, the incidence of SVD at five years was 2.20% in the transcatheter group, compared to 4.38% in the surgical group. Additionally, the clinical study found that SVD was associated with increased 5-year all-cause mortality, cardiovascular mortality, and valve disease or worsening heart failure hospitalizations.

Are you interested in clinical trials near you?

You can receive free notification of a trial for this, or any other condition, by completing a short confidential health profile.
Find a clinical trial near me

What Does This Mean for Patients?

The results of this study suggest that patients who undergo self-expanding transcatheter aortic valve replacement may be at a lower risk of developing SVD than those who undergo surgical aortic valve replacement.

These findings are significant because they emphasize the importance of regular follow-up to monitor for any signs of valve dysfunction or deterioration. Symptoms such as shortness of breath, chest pain, and fatigue should be reported immediately to your healthcare provider.

Conclusion

Structural valve deterioration is a serious complication that can occur after aortic valve replacement. While the risk of SVD is relatively low, the results of this clinical study suggest that patients who undergo self-expanding transcatheter aortic valve replacement may be at a lower risk of developing SVD than those who undergo surgical aortic valve replacement. It is important for patients to regularly follow up with their healthcare provider and discuss the benefits and risks of each type of aortic valve replacement procedure.
__________
JAMA Cardiology, Dec-14-22
ClinicalTrials.gov NCT01240902, NCT01586910, NCT01531374





Share this article with a friend:
     


Get emailed clinical trial results in the categories of your choice:
Free subscription to clinical trial results

20,000 clinical trials are seeking participants.
Signup and be matched to trials near you
This free service will notify you of current and future clinical trial matches.


This content is for informational and educational purposes only. It is not intended to provide medical advice or to take the place of such advice or treatment from a personal physician. All readers/viewers of this content are advised to consult their doctors or qualified health professionals regarding specific health questions. CenTrial Data Ltd. does not take responsibility for possible health consequences of any person or persons reading or following the information in this educational content. Treatments and clinical trials mentioned may not be appropriate or available for all trial participants. Outcomes from treatments and clinical trials may vary from person to person. Consult with your doctor as to whether a clinical trial is a suitable option for your condition. Assistance from generative AI tools may have been used in writing this article.